Renalys Pharma Announces Support for Alport Syndrome Registry Study Organized by Japanese Society for Pediatric Nephrology
TOKYO, Oct. 22, 2025 /PRNewswire/ -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") is pleased to announce the company is providing financial support for the Alport Syndrome Registry Study organized by the Japanese Society for...
Toshiba's Heavy Ion Therapy System CI-1000 Wins Minister of Economy, Trade and Industry Award and GOOD DESIGN GOLD AWARD at GOOD DESIGN AWARD 2025
-Four designs awarded GOOD DESIGN AWARD- KAWASAKI, Japan, Oct. 22, 2025 /PRNewswire/ -- Toshiba Group has announced that its heavy ion therapy system CI-1000 was honored with a GOOD DESIGN GOLD AWARD and the highly regarded Minister of Economy,...
CAAS Introduces Rear-Wheel Active Steering Technology to Upper Mass-Market EVs in China
WUHAN, China, Oct. 21, 2025 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China, today announced that with the rapid growth of automotive...
MMA Global Launches Bold New Era as the Marketing + Media Alliance, Advancing Marketers' Ability to Create Value
MMA's next chapter outlines what it means to lead proven marketing transformation, powered by groundbreaking, award-winning, CMO-validated models, frameworks, and knowledge SINGAPORE, Oct. 21, 2025 /PRNewswire/ -- MMA Global, Inc., the global...
SM Investments certified as a Great Place to Work® in 2025
PASAY CITY, Philippines , Oct. 20, 2025 /PRNewswire/ -- SM Investments Corporation (SM Investments), the parent company of the SM group, has been certified as a Great Place to Work for 2025 by the global authority on workplace culture, Great Place...
Positive Results from Phase 3 OptiTROP-Lung04 Trial of Sacituzumab Tirumotecan Presented at ESMO Presidential Symposium and Simultaneously Published in NEJM
CHENGDU, China, Oct. 20, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3...
Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO
CHENGDU, China, Oct. 18, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that at the 2025 European Society for Medical Oncology (ESMO) Congress held in Berlin, Germany, results from a Phase 3...
I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences
New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for patients worldwide Intention to pursue a Hong Kong...
LANZAJET WINS REUTERS GLOBAL ENERGY TRANSITION AWARD FOR ACCELERATING DECARBONIZATION
Reuters Honors LanzaJet's Pioneering Alcohol-to-Jet Technology, a Breakthrough Sustainable Aviation Fuel Solution CHICAGO, June 25, 2025 /PRNewswire/ -- LanzaJet, Inc., a leading next-gen fuels technology company and producer of sustainable fuels,...
EDAN Establishes Mexico Subsidiary to Strengthen Presence in the Americas
MEXICO CITY, June 25, 2025 /PRNewswire/ -- EDAN Instruments, Inc. (300206.SZ), a healthcare company and medical device manufacturer, officially celebrated the opening of its new subsidiary, EDAN MEDICAL MÉXICO S de R.L. de C.V., with a...